The purpose of Innovative Collaborations with Singapore in Quantum or Synthetic Biology is to give Sweden a technological leap and Swedish organizations a competitive advantage through access to innovation and collaboration opportunities with one of the world's most innovative and dynamic ecosystems. Singapore is a leading country in research and development in emerging technologies, as well as a strategically located hub in Southeast Asia for innovation and entrepreneurship. The country possesses a unique mix of global technology companies, startups and leading research institutions - and thus plays a central role in global development.
Sweden is one of the world's most innovative countries. So is Singapore. Both countries are relatively small in terms of area and population, have limited domestic markets and are heavily dependent on research and development and global talent. Innovative countries can achieve a lot on their own, but working together can create even more value. For Sweden to achieve its overall objective around competitiveness, resilience and sustainability, strong international partners are required.
This the offer aims to strengthen Sweden's position on the global technology scene. The offer provides an opportunity to further strengthen the important trade and investment relationship between Sweden and Singapore and strengthen the conditions for long-term sustainable collaborations.
In this offer the focus is on the areas of quantum technology and synthetic biology.
Quantum technology
Quantum technology here refers to: computers, simulations, encryption, communication, detection, metrology.
Applications are expected to be within, for example:
- Increased and accelerated utilization in terms of usability, dissemination, accessibility and security.
- New applications for quantum technology.
- Reduced resource requirements, regarding energy and power consumption as well as production and operating costs.
Synthetic biology
Synthetic biology is an emerging field of research and innovation in the bioeconomy that draws on advanced research in biology, chemistry, computer science and engineering to design and build complex biological systems with functions that do not exist in nature. The technology makes it possible to construct entirely new living organisms and to modify existing creatures, plants or other biological materials so that they acquire new or improved properties. Examples of applications include food, energy and medicine.
Applications are expected to be within, for example:
- Gene synthesis
- Gene sequencing
- Gene editing
- Designed biological platforms, applications
- Scale-up methods, from lab, biofoundry to manufacturing
Two-step Offer
Erbjudandet Innovativa collaborations with Singapore in quantum or synthetic biology are a two-step effort. The first step aims to provide the conditions for creating collaborations with actors in Singapore. In step 2, you can receive support for the R&D project that the collaboration during step 1 results in. Funding for step 1 does not guarantee that you will be granted support for step 2.
Step 1
Step 1 aims to promote partnerships between Sweden and Singapore in quantum or synthetic biology.
Stage 1 is a feasibility study focusing on personnel costs and travel. We fund project that are approximately 3–5 months long, starting in the fall of 2024. Stage 1 includes:
- Preparation of the funded the actors for their stay in Singapore
- Stay in Singapore for 2-3 weeks where you make contacts
- Deepened collaborations and planning for stage 2.
The objective of Step 1 is to identify and establish relevant partnerships with actors in Singapore .Work on an upcoming proposal for an R&D project in Step 2 is not an eligible cost and cannot be included in Step 1.
Feasibility study is defined as:
Evaluation and analysis of the potential of a project aimed at supporting the decision-making process by objectively and rationally revealing the project's strengths and weaknesses, opportunities and risks, as well as identifying the resources required to implement it, and finally the prospects for the project's success. This refers to studies for project involving basic research, industrial research or experimental development.
Vinnova does not finance routine business development, customer acquisition, marketing or other ordinary business-related activities.
Step 2
Step 1 is followed by a possible second step. project that have been granted funding in step 1 are invited to apply for step 2, which must be a research or development project where bilateral cooperation is in focus. Funds will be available for activities carried out in both Sweden and Singapore. The project coordinator for step 2 must have an establishment in Sweden and a Swedish business registration number. Proposal for step 2 are only open to project that have been granted support in this call for proposals, Innovative collaborations with Singapore in quantum or synthetic biology - step 1.
The projects in stage 2 should represent new collaborations with a high level of innovation and good development potential. If there is a previous collaboration, the project for which funding is sought should constitute a significant further development of the collaboration.
I FoU-projektet, which is carried out in stage 2, great importance is placed on the degree to which the project represents a new collaboration. It will also be important to demonstrate that the new project constellation possesses the competence and capabilities required to realize the potential. These criteria will be presented in more detail in the call for proposal for stage 2.
Funding in stage 2 is offered for smaller R&D project in quantum or synthetic biology where bilateral collaboration is in focus. Each project can apply for a maximum of 1 million SEK in funding in stage 2 and the preliminary budget for stage 2 is a total of 4 million.
The call for proposals for stage 2 will open in 2025.
Focus on climate and gender equality in all our initiatives
Vinnova is tasked with promoting sustainable growth and social development. Genom Agenda 2030, the world's countries have agreed on a global agreement and understanding of what characterizes sustainable development. Through our efforts, we contribute to the global commitment to achieving the goals.
Inom Agenda 2030, Vinnova has specifically identified climate and gender equality as two central sustainability perspectives that our funded initiatives will contribute positively to. Project funded by Vinnova are therefore expected to take special account of climate and gender equality aspects.
One aspect that Vinnova follows up and assesses is whether both women and men equally benefit from the grant, participate in and have influence over the project. This aspect is assessed under the actor criterion, see section 7.
Another aspect is to analyze and decide whether there are sex or gender aspects that are relevant to the project's problem area, solutions and utilization. This question is mandatory for all applicant and is found under the heading " Project tasks". In this call for proposals the question forms the basis for assessment and is assessed under the Potential criterion, see section 7.
Our work to contribute to the goals of Agenda 2030
Gender-equal innovation – what it means for those seeking funding from us
Free access to scientific publications and results
Results from research and innovation that are made freely available increase the opportunity for more people to contribute to solutions to societal challenges. This the call for proposals will contribute to making more results freely available to everyone. Therefore, all scientific publishing should be open access.